Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

• Main Authors: Rodolfo Pedro Rothlin (Author), Mariano Duarte (Author), Facundo Germán Pelorosso (Author), Liliana Nicolosi (Author), M. Victoria Salgado (Author), Héctor Miguel Vetulli (Author), Eduardo Spitzer (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

COVID-19 pandemic demands a swift response to find therapeutic tools that effectively reduce morbidity and mortality. Despite initial fears, evidence from retrospective observational studies supports the inhibition of the renin-angiotensin system as an emerging pathway to delay or moderate angiotens...